IP Library › Assignment 053515/0765
Patent Assignment
Reel/Frame 053515/0765

Security Interest

Recorded: 2020-08-17 Pages: 10
Assignor
ALNYLAM PHARMACEUTICALS, INC.
Executed: 2020-08-15
Assignee
BXLS V BODYGUARD - PCP L.P., AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
101 MAIN STREET; SUITE 1210, C/O BLACKSTONE LIFE SCIENCES, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties (27)
ANGIOTENSINOGEN (AGT) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
Application: 62/001,731 →
ANGIOTENSINOGEN (AGT) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
Application: 62/047,978 →
ANGIOTENSINOGEN (AGT) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
Application: 16/274,393 →
Publication: US US20190298842A1
Antisense Polynucleotide Agents Targeting Angiotensinogen (Agt) and Methods of Use Thereof
Application: 62/169,055 →
Polynucleotide Agents Targeting Angiotensinogen (Agt) and Methods of Use Thereof
Application: 16/891,155 →
Publication: US US20210169915A1
Angiotensinogen (Agt) Irna Compositions and Methods of Use Thereof
Application: 62/671,094 →
ANGIOTENSINOGEN (AGT) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
Application: 62/727,141 →
ANGIOTENSINOGEN (AGT) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
Application: 62/816,996 →
Angiotensinogen (Agt) Irna Compositions and Methods of Use Thereof
Application: 62/934,695 →
Angiotensinogen (Agt) Irna Compositions and Methods of Use Thereof
Application: 63/017,854 →
Methods of Treating Transthyretin (Ttr) Associated Diseases
Application: 61/615,618 →
Methods of Treating Transthyretin (Ttr) Associated Diseases
Application: 61/680,098 →
Rnai Agents, Compositions and Methods of Use Thereof for Treating Transthyretin (Ttr) Associated Diseases
Application: 16/738,014 →
Publication: US US20200318111A1
TRANSTHYRETIN (TTR) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED DISEASES
Application: 62/199,563 →
TRANSTHYRETIN (TTR) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED DISEASES
Application: 62/287,518 →
Transthyretin (Ttr) Irna Compositions and Methods of Use Thereof for Treating or Preventing Ttr-Associated Diseases
Application: 16/864,226 →
Publication: US US20200377889A1
METHODS FOR TREATING OR PREVENTING TTR-ASSOCIATED DISEASES USING TRANSTHYRETIN (TTR) iRNA COMPOSITIONS
Application: 62/435,127 →
METHODS FOR TREATING OR PREVENTING TTR-ASSOCIATED DISEASES USING TRANSTHYRETIN (TTR) iRNA COMPOSITIONS
Application: 16/468,953 →
Publication: US US20190350962A1
TRANSTHYRETIN (TTR) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED OCULAR DISEASES
Application: 62/738,256 →
TRANSTHYRETIN (TTR) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED OCULAR DISEASES
Application: 62/844,174 →
Compositions and Methods for Inhibiting Expression of Transthyretin (Ttr)
Application: 62/985,950 →
ANGIOTENSINOGEN (AGT) iRNA COMPOSITIONS AND METHODS OF USE THEREOF
Application: 15/313,145 →
Publication: US US20170189541A1
Polynucleotide Agents Targeting Angiotensinogen (Agt) and Methods of Use Thereof
Application: 15/578,955 →
Publication: US US20180169129A1
Rnai Agents, Compositions and Methods of Use Thereof for Treating Transthyretin (Ttr) Associated Diseases
Patent: 9,399,775 →
Application: 14/358,972 →
Publication: US US20140315835A1
Rnai Agents, Compositions and Methods of Use Thereof for Treating Transthyretin (Ttr) Associated Diseases
Application: 15/188,317 →
Publication: US US20160355817A1
Transthyretin (Ttr) Irna Compositions and Methods of Use Thereof for Treating or Preventing Ttr-Associated Diseases
Application: 15/221,651 →
Publication: US US20170029817A1
TRANSTHYRETIN (TTR) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED DISEASES
Application: 16/223,362 →
Publication: US US20190345492A1
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 3, 2012
From: ZIMMERMANN, TRACY; RAJEEV, KALLANTHOTTATHIL G.; MANOHARAN, MUTHIAH; MAIER, MARTIN
To: ALNYLAM PHARMACEUTICALS
Reel/Frame 029069/0880 →
Assignment of Assignor's Interest Oct 3, 2012
From: RAJEEV, KALLANTHOTTATHIL G.; ZIMMERMANN, TRACY; MANOHARAN, MUTHIAH; MAIER, MARTIN
To: ALNYLAM PHARMACEUTICALS
Reel/Frame 029069/0689 →
Assignment of Assignor's Interest Jun 4, 2014
From: FOSTER, DONALD; BETTENCOURT, BRIAN
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 033025/0004 →
Assignment of Assignor's Interest Oct 16, 2014
From: FOSTER, DONALD; BETTENCOURT, BRIAN
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 033962/0882 →
Assignment of Assignor's Interest May 21, 2015
From: CHARISSE, KLAUS; HINKLE, GREGORY; MILSTEIN, STUART
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 035686/0603 →
Assignment of Assignor's Interest May 21, 2015
From: CHARISSE, KLAUS; HINKLE, GREGORY; MILSTEIN, STUART
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 035686/0610 →
Assignment of Assignor's Interest Oct 7, 2015
From: ZIMMERMANN, TRACY; CHAN, AMY; JADHAV, VASANT; MAIER, MARTIN
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 036747/0424 →
Assignment of Assignor's Interest Oct 20, 2015
From: HINKLE, GREGORY
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 036831/0150 →
Assignment of Assignor's Interest Apr 25, 2016
From: RAJEEV, KALLANTHOTTATHIL G.; ZIMMERMANN, TRACY; MANOHARAN, MUTHIAH; CHARISSE, KLAUS
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 038370/0389 →
Assignment of Assignor's Interest Jun 30, 2016
From: ZIMMERMANN, TRACY; CHAN, AMY; JADHAV, VASANT; MAIER, MARTIN
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 039056/0207 →
Assignment of Assignor's Interest Jul 15, 2016
From: RAJEEV, KALLANTHOTTATHIL G.; ZIMMERMANN, TRACY; MANOHARAN, MUTHIAH; CHARISSE, KLAUS
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 039167/0589 →
Assignment of Assignor's Interest Jul 28, 2016
From: ZIMMERMANN, TRACY; CHAN, AMY; JADHAV, VASANT; MAIER, MARTIN
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 039282/0009 →
Assignment of Assignor's Interest Dec 16, 2016
From: FOSTER, DONALD; BETTENCOURT, BRIAN; CHARISSE, KLAUS; HINKLE, GREGORY
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 040640/0977 →
Assignment of Assignor's Interest Aug 4, 2017
From: CHAN, AMY
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 043195/0858 →
Assignment of Assignor's Interest Dec 15, 2017
From: VEST, JOHN; ROBBIE, GABRIEL; ATTARWALA, HUSAIN Z.; GOEL, VARUN
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 044408/0770 →
Assignment of Assignor's Interest Feb 21, 2018
From: HINKLE, GREGORY
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 044989/0950 →
Assignment of Assignor's Interest Jul 12, 2018
From: FOSTER, DONALD; HINKLE, GREGORY; SCHLEGEL, MARK K.; ALNYLAM PHARMACEUTICALS, INC.
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 046328/0234 →
Assignment of Assignor's Interest Feb 21, 2019
From: FOSTER, DONALD; BETTENCOURT, BRIAN; CHARISSE, KLAUS; HINKLE, GREGORY
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 048394/0130 →
Assignment of Assignor's Interest Feb 21, 2019
From: ZIMMERMANN, TRACY; CHAN, AMY; JADHAV, VASANT; MAIER, MARTIN
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 048393/0867 →
Assignment of Assignor's Interest Apr 25, 2019
From: FOSTER, DONALD; HINKLE, GREGORY; SCHLEGEL, MARK K.
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 048990/0030 →
Assignment of Assignor's Interest Sep 26, 2019
From: NAIR, JAYAPRAKASH K.; MAIER, MARTIN A.; JADHAV, VASANT R.; KEATING, MARK
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 050497/0501 →
Assignment of Assignor's Interest Dec 11, 2019
From: CHAN, AMY; VEST, JOHN; ROBBIE, GABRIEL; ATTARWALA, HUSAIN Z.
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 051246/0589 →
Assignment of Assignor's Interest Feb 21, 2020
From: RAJEEV, KALLANTHOTTATHIL G.; ZIMMERMANN, TRACY; MANOHARAN, MUTHIAH; CHARISSE, KLAUS
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 051884/0004 →
Security Interest Apr 13, 2020
From: ALNYLAM PHARMACEUTICALS, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 052381/0156 →
Assignment of Assignor's Interest May 28, 2020
From: ZIMMERMANN, TRACY; CHAN, AMY; JADHAV, VASANT; MAIER, MARTIN
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 052775/0312 →